Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul;36(4):1454-1459.
doi: 10.1111/jvim.16471. Epub 2022 Jul 11.

A novel mutation of the CLCN1 gene in a cat with myotonia congenita: Diagnosis and treatment

Christian Woelfel  1 , Kathryn Meurs  1 , Steven Friedenberg  2 , Nicole DeBruyne  1 , Natasha J Olby  1
Affiliations
Case Reports

A novel mutation of the CLCN1 gene in a cat with myotonia congenita: Diagnosis and treatment

Christian Woelfel et al. J Vet Intern Med. 2022 Jul.

Abstract

Case description: A 10-month-old castrated male domestic longhair cat was evaluated for increasing frequency of episodic limb rigidity.

Clinical findings: The cat presented for falling over and lying recumbent with its limbs in extension for several seconds when startled or excited. Upon examination, the cat had hypertrophied musculature, episodes of facial spasm, and a short-strided, stiff gait.

Diagnostics: Electromyography (EMG) identified spontaneous discharges that waxed and waned in amplitude and frequency, consistent with myotonic discharges. A high impact 8-base pair (bp) deletion across the end of exon 3 and intron 3 of the chloride voltage-gated channel 1 (CLCN1) gene was identified using whole genome sequencing.

Treatment and outcome: Phenytoin treatment was initiated at 3 mg/kg po q24 h and resulted in long-term improvement.

Clinical relevance: This novel mutation within the CLCN1 gene is a cause of myotonia congenita in cats and we report for the first time its successful treatment.

Keywords: chloride channel; electromyography; nondystrophic myotonia; phenytoin.

PubMed Disclaimer

Conflict of interest statement

Authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Alignment of the nucleotide sequence from the proband (affected cat) against the reference sequence (UCSC felCat9, top) verifies the presence of an 8 bp deletion at the location chrA2:15897085‐15897092 in chloride voltage‐gated channel 1 (CLNC1)
FIGURE 2
FIGURE 2
(A) The wild‐type nucleotide and codon sequence at the end of exon 3 and the beginning of intron 3 of feline chloride voltage‐gated channel 1 (CLNC1) is shown, with the corresponding reading frame highlighted in yellow. (B) The mutated nucleotide sequence is shown with the deleted nucleotides blacked out, and the adjusted reading frame is highlighted in yellow. The new codon sequence showing the creation of a stop codon is presented below
FIGURE 3
FIGURE 3
The predicted wild‐type and mutant protein structures of chloride voltage‐gated channel 1 (CLNC1), as modeled by I‐Tasser and visualized in Geneious Prime. The pink color represents alpha helices and yellow represents beta sheets
See this image and copyright information in PMC

References

    1. Vite CH. Myotonia and disorders of altered muscle cell membrane excitability. Vet Clins North Am Sm Anil Pract. 2002;32(1):169‐187. - PubMed
    1. Matthews E, Fialho D, Tan SV, et al. The non‐dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain. 2010;133(1):9‐22. - PMC - PubMed
    1. Morales F, Pusch M. An up‐to‐date overview of the complexity of genotype‐phenotype relationships in myotonic channelopathies. Front Neurol. 2019;10:1404. - PMC - PubMed
    1. Heatwole CR, Moxley RT. The nondystrophic myotonias. Neurotherapeutics. 2007;4(2):238‐251. - PubMed
    1. Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 2012;11:891‐905. - PubMed

Publication types

Substances